These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8082507)

  • 1. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.
    Marks JW; Stein T; Schoenfield LJ
    Dig Dis Sci; 1994 Sep; 39(9):1981-4. PubMed ID: 8082507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.
    Sugerman HJ; Brewer WH; Shiffman ML; Brolin RE; Fobi MA; Linner JH; MacDonald KG; MacGregor AM; Martin LF; Oram-Smith JC
    Am J Surg; 1995 Jan; 169(1):91-6; discussion 96-7. PubMed ID: 7818005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones.
    Tint GS; Dyrszka H; Sanghavi B; Patel G; Patel S; Shefer S; Salen G
    Gastroenterology; 1992 Jun; 102(6):2042-9. PubMed ID: 1587422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss.
    Marks JW; Bonorris GG; Schoenfield LJ
    Dig Dis Sci; 1996 Feb; 41(2):242-9. PubMed ID: 8601365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction.
    Shoheiber O; Biskupiak JE; Nash DB
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1038-45. PubMed ID: 9368828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.
    Marks JW; Bonorris GG; Schoenfield LJ
    Dig Dis Sci; 1991 Jul; 36(7):957-60. PubMed ID: 1906399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodiol for hepatobiliary disorders.
    Rubin RA; Kowalski TE; Khandelwal M; Malet PF
    Ann Intern Med; 1994 Aug; 121(3):207-18. PubMed ID: 8017748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
    Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
    Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal shock-wave lithotripsy and ursodiol versus ursodiol alone in the treatment of gallstones.
    Ertan A; Hernandez RE; Campeau RJ; Geshner JR; Litwin MS
    Gastroenterology; 1992 Jul; 103(1):311-6. PubMed ID: 1612339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.
    Schoenfield LJ; Berci G; Carnovale RL; Casarella W; Caslowitz P; Chumley D; Davis RC; Gillenwater JY; Johnson AC; Jones RS
    N Engl J Med; 1990 Nov; 323(18):1239-45. PubMed ID: 2215608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G
    J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.
    Burnett D; Ertan A; Jones R; O'Leary JP; Mackie R; Robinson JE; Salen G; Stahlgren L; Van Thiel DH; Vassy L
    Dig Dis Sci; 1989 Jul; 34(7):1011-5. PubMed ID: 2663386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
    Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
    Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 19. Actigall (ursodiol) capsules/CIBA.
    Swartz ML
    Gastroenterol Nurs; 1991; 13(4):223-6. PubMed ID: 2031947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of gallstones: a cost-effectiveness analysis.
    Weinstein MC; Coley CM; Richter JM
    J Gen Intern Med; 1990; 5(4):277-84. PubMed ID: 2115575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.